0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

gavreto_img

Click to enlarge

Previous product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Onureg (azacitidine) CHF34,970.00

Back to products

Next product

Retevmo (selpercatinib) CHF15,720.75

Gavreto (pralsetinib)

CHF17,615.00

Gavreto (pralsetinib) is a medication used for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) and adults with advanced or metastatic thyroid cancer.

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Gavreto (pralsetinib)”

Start typing to see products you are looking for.

No account yet?

Create an Account